REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Onopb AO (Russia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Omutninskaya Nauchnaya Opytno-Promyshlennaya Baza AO Profile Updated: March 06, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Russian Download a sample report

onopb is a contract production company specializing in biological, microbiological, and chemical synthesis for industrial production, with a focus on the pharmaceutical industry. The company offers necessary production capacities and services.

Headquarters
Obl. Kirovskaya, Omutninskii R-N, Ter. Doroga Vostochnyi-Filippovka, K. 1, Str. 3
Kirov Oblast; Kirov Oblast; Postal Code: 612711

Contact Details: Purchase the Onopb AO report to view the information.

Website: http://onopb.ru

Basic Information
Total Employees:
Purchase the Onopb AO report to view the information.
Outstanding Shares:
Purchase the Onopb AO report to view the information.
Registered Capital:
Purchase the Onopb AO report to view the information.
Incorporation Date:
June 13, 2001
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Onopb AO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
39.72%▲
Total operating revenue
39.72%▲
Operating profit (EBIT)
27.93%▲
Net Profit (Loss) for the Period
-19.96%▼
Total assets
6.26%▲
Total equity
11.08%▲
Operating Profit Margin (ROS)
-2.88%▼
Net Profit Margin
-9.45%▼
Return on Equity (ROE)
-3.48%▼
Debt to Equity Ratio
-4.34%▼
Quick Ratio
0.36%▲
Cash Ratio
0.34%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo